The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective
Open accessAbstract
Uric acid (UA) is the end product of purine nucleotide metabolism in the human body. Hyperuricemia is an abnormally high level of UA in the blood and may result in arthritis and gout. The prevalence of hyperuricemia has been increasing globally. Epidemiological studies have shown that UA levels are positively correlated with cardiovascular diseases, including hypertension, atherosclerosis, atrial fibrillation (AF), and heart failure (HF). Hyperuricemia promotes the occurrence and development of cardiovascular diseases by regulating molecular signals, such as inflammatory response, oxidative stress, insulin resistance/diabetes, endoplasmic reticulum stress, and endothelial dysfunction. Despite extensive research, the underlying molecular mechanisms are still unclear. Allopurinol, a xanthine oxidase (XO) inhibitor, has been shown to improve cardiovascular outcomes in patients with HF, coronary heart disease (CHD), type 2 diabetes (T2D), and left ventricular hypertrophy (LVH). Whether febuxostat, another XO inhibitor, can improve cardiovascular outcomes as well as allopurinol remains controversial. Furthermore, it is also not clear whether UA-lowering treatment (ULT) can benefit patients with asymptomatic hyperuricemia. In this review, we focus on the latest cellular and molecular findings of cardiovascular disease associated with hyperuricemia and clinical data about the efficacy of ULT in patients with cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
High Uric Acid Inhibits Cardiomyocyte Viability Through the ERK/P38 Pathway via Oxidative Stress
Li, Z., Shen, Y., Chen, Y., Zhang, G., Cheng, J., & Wang, W. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487356 · Cited by 60
Self-citationRetractedEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Ames, B. N., Cathcart, R., Schwiers, E., & Hochstein, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6858 · Cited by 2,909
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
Culleton, B. F., Larson, M. G., Kannel, W. B., & Levy, D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00003 · Cited by 1,282
Uric Acid: The Oxidant-Antioxidant Paradox
Sautin, Y. Y., & Johnson, R. J. (2008) · Nucleosides, Nucleotides and Nucleic Acids · doi:10.1080/15257770802138558 · Cited by 972
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
White, W. B., Saag, K. G., Becker, M. A., Borer, J. S., Gorelick, P. B., Whelton, A., Hunt, B., Castillo, M., & Gunawardhana, L. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710895 · Cited by 909
Bailey, C. J., Gross, J. L., Pieters, A., Bastien, A., & List, J. F. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60407-2 · Cited by 860
Hyperuricemia and incident hypertension: A systematic review and meta‐analysis
Grayson, P. C., Kim, S. Y., LaValley, M., & Choi, H. K. (2011) · Arthritis Care & Research · doi:10.1002/acr.20344 · Cited by 756
Corry, D. B., Eslami, P., Yamamoto, K., Nyby, M. D., Makino, H., & Tuck, M. L. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f240bf · Cited by 751
Johnson, R. J., Bakris, G. L., Borghi, C., Chonchol, M. B., Feldman, D., Lanaspa, M. A., Merriman, T. R., Moe, O. W., Mount, D. B., Sanchez Lozada, L. G., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.12.009 · Cited by 644
Yu, M.-A., Sánchez-Lozada, L. G., Johnson, R. J., & Kang, D.-H. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328337da1d · Cited by 626
George, J., Carr, E., Davies, J., Belch, J. J. F., & Struthers, A. (2006) · Circulation · doi:10.1161/circulationaha.106.651117 · Cited by 569
Doehner, W., Schoene, N., Rauchhaus, M., Leyva-Leon, F., Pavitt, D. V., Reaveley, D. A., Schuler, G., Coats, A. J. S., Anker, S. D., & Hambrecht, R. (2002) · Circulation · doi:10.1161/01.cir.0000017502.58595.ed · Cited by 565
Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid
Davies, K. J. A., Sevanian, A., Muakkassah-Kelly, S. F., & Hochstein, P. (1986) · Biochemical Journal · doi:10.1042/bj2350747 · Cited by 558
Association Between Serum Uric Acid and Development of Type 2 Diabetes
Kodama, S., Saito, K., Yachi, Y., Asumi, M., Sugawara, A., Totsuka, K., Saito, A., & Sone, H. (2009) · Diabetes Care · doi:10.2337/dc09-0288 · Cited by 549
Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure
Farquharson, C. A. J., Butler, R., Hill, A., Belch, J. J. F., & Struthers, A. D. (2002) · Circulation · doi:10.1161/01.cir.0000022140.61460.1d · Cited by 504
Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid
Bigoni, M., Turati, M., Gandolla, M., Sacerdote, P., Piatti, M., Castelnuovo, A., Franchi, S., Gorla, M., Munegato, D., Gaddi, D., et al. (2016) · Mediators of Inflammation · doi:10.1155/2016/8243601 · Cited by 431
Noman, A., Ang, D. S., Ogston, S., Lang, C. C., & Struthers, A. D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60391-1 · Cited by 348
URic Acid and Risk Of Heart Failure: A Systematic Review and Meta-Analysis
Huang, H., Huang, B., Li, Y., Huang, Y., Li, J., Yao, H., Jing, X., Chen, J., & Wang, J. (2014) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft132 · Cited by 339
Zhao, Y., Xu, L., Tian, D., Xia, P., Zheng, H., Wang, L., & Chen, L. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13101 · Cited by 333
Systemic Uric Acid Administration Increases Serum Antioxidant Capacity in Healthy Volunteers
W. Waring, S., J. Webb, D., & R. J. Maxwell, S. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200109000-00005 · Cited by 294
Virdis, A., Masi, S., Casiglia, E., Tikhonoff, V., Cicero, A. F. G., Ungar, A., Rivasi, G., Salvetti, M., Barbagallo, C. M., Bombelli, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.13643 · Cited by 279
Li, M., Hu, X., Fan, Y., Li, K., Zhang, X., Hou, W., & Tang, Z. (2016) · Scientific Reports · doi:10.1038/srep19520 · Cited by 257
Hyperuricemia and endothelial function: From molecular background to clinical perspectives
Maruhashi, T., Hisatome, I., Kihara, Y., & Higashi, Y. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.10.007 · Cited by 242
Kuwabara, M., Niwa, K., Hisatome, I., Nakagawa, T., Roncal-Jimenez, C. A., Andres-Hernando, A., Bjornstad, P., Jensen, T., Sato, Y., Milagres, T., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08998 · Cited by 232
Gout and hyperuricaemia in the USA: prevalence and trends
Singh, G., Lingala, B., & Mithal, A. (2019) · Rheumatology · doi:10.1093/rheumatology/kez196 · Cited by 230
Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk
Mercuro, G., Vitale, C., Cerquetani, E., Zoncu, S., Deidda, M., Fini, M., & Rosano, G. M. C. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.06.032 · Cited by 223
Kuwabara, M., Hisatome, I., Niwa, K., Hara, S., Roncal-Jimenez, C. A., Bjornstad, P., Nakagawa, T., Andres-Hernando, A., Sato, Y., Jensen, T., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10370 · Cited by 217
The role of xanthine oxidoreductase and uric acid in metabolic syndrome
Battelli, M. G., Bortolotti, M., Polito, L., & Bolognesi, A. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.05.003 · Cited by 209
Hyperuricemia, Type 2 Diabetes Mellitus, and Hypertension: an Emerging Association
Mortada, I. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0770-x · Cited by 194
Aroor, A. R., DeMarco, V. G., Jia, G., Sun, Z., Nistala, R., Meininger, G. A., & Sowers, J. R. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00161 · Cited by 193
A Reassessment of the Peroxynitrite Scavenging Activity of Uric Acid
WHITEMAN, M., KETSAWATSAKUL, U., & HALLIWELL, B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04072.x · Cited by 184
Braga, F., Pasqualetti, S., Ferraro, S., & Panteghini, M. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-0523 · Cited by 181
Uric Acid Induces Endothelial Dysfunction by Activating the HMGB1/RAGE Signaling Pathway
Cai, W., Duan, X.-M., Liu, Y., Yu, J., Tang, Y.-L., Liu, Z.-L., Jiang, S., Zhang, C.-P., Liu, J.-Y., & Xu, J.-X. (2017) · BioMed Research International · doi:10.1155/2017/4391920 · Cited by 178
Kushiyama, A., Nakatsu, Y., Matsunaga, Y., Yamamotoya, T., Mori, K., Ueda, K., Inoue, Y., Sakoda, H., Fujishiro, M., Ono, H., et al. (2016) · Mediators of Inflammation · doi:10.1155/2016/8603164 · Cited by 174
Cicero, A. F. G., Salvi, P., D’Addato, S., Rosticci, M., & Borghi, C. (2014) · Journal of Hypertension · doi:10.1097/hjh.0b013e328365b916 · Cited by 170
Kimura, Y., Yanagida, T., Onda, A., Tsukui, D., Hosoyamada, M., & Kono, H. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313224 · Cited by 165
Kuwabara, M., Borghi, C., Cicero, A. F. G., Hisatome, I., Niwa, K., Ohno, M., Johnson, R. J., & Lanaspa, M. A. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.03.045 · Cited by 162
XIAO, J., ZHANG, X.-L., FU, C., HAN, R., CHEN, W., LU, Y., & YE, Z. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2148 · Cited by 159
LI, P., ZHANG, L., ZHANG, M., ZHOU, C., & LIN, N. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2491 · Cited by 159
High-Dose Allopurinol Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease
Rekhraj, S., Gandy, S. J., Szwejkowski, B. R., Nadir, M. A., Noman, A., Houston, J. G., Lang, C. C., Casella, G., & Struthers, A. D. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.066 · Cited by 157
Struthers, A. D., Donnan, P. T., Lindsay, P., McNaughton, D., Broomhall, J., & MacDonald, T. M. (2002) · Heart · doi:10.1136/heart.87.3.229 · Cited by 147
Uric Acid Promotes Left Ventricular Diastolic Dysfunction in Mice Fed a Western Diet
Jia, G., Habibi, J., Bostick, B. P., Ma, L., DeMarco, V. G., Aroor, A. R., Hayden, M. R., Whaley‐Connell, A. T., & Sowers, J. R. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.04737 · Cited by 145
Wilcox, C. S., Shen, W., Boulton, D. W., Leslie, B. R., & Griffen, S. C. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007046 · Cited by 139
Zhang, M., Solomon, D. H., Desai, R. J., Kang, E. H., Liu, J., Neogi, T., & Kim, S. C. (2018) · Circulation · doi:10.1161/circulationaha.118.033992 · Cited by 137
Matias, M. L., Romão‐Veiga, M., Weel, I. C., Ribeiro, V. R., Nunes, P. R., Borges, V. T. M., Araújo, J. P., Peraçoli, J. C., Oliveira, L. G., & Peraçoli, M. T. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129095 · Cited by 135
Status of Endothelial Dependent Vasodilation in Patients With Hyperuricemia
Kato, M., Hisatome, I., Tomikura, Y., Kotani, K., Kinugawa, T., Oginö, K., Ishida, K., Igawa, O., Shigemasa, C., & Somers, V. K. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.068 · Cited by 134
Allopurinol and Cardiovascular Outcomes in Adults With Hypertension
MacIsaac, R. L., Salatzki, J., Higgins, P., Walters, M. R., Padmanabhan, S., Dominiczak, A. F., Touyz, R. M., & Dawson, J. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06344 · Cited by 124
Uric Acid and Insulin Sensitivity and Risk of Incident Hypertension
Forman, J. P., Choi, H. K., & Curhan, G. C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.521 · Cited by 124
Szwejkowski, B. R., Gandy, S. J., Rekhraj, S., Houston, J. G., Lang, C. C., Morris, A. D., Casella, G., & Struthers, A. D. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.074 · Cited by 116
Tamariz, L. J., Agarwal, S. K., Soliman, E. Z., Chamberlain, A. M., Prineas, R. J., Folsom, A. R., Ambrose, M., & Alonso, Á. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.06.043 · Cited by 115
Hyperuricemia is an independent competing risk factor for atrial fibrillation
Kuwabara, M., Niwa, K., Nishihara, S., Nishi, Y., Takahashi, O., Kario, K., Yamamoto, K., Yamashita, T., & Hisatome, I. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.268 · Cited by 115
Bjornstad, P., Laffel, L. M., Lynch, J. L., ghormli, L. K. E., Weinstock, R. S., Tollefsen, S. E., Nadeau, K. J., & for the TODAY Study Group (2019) · Diabetes Care · doi:10.2337/dc18-2147 · Cited by 113
Mineralocorticoid receptors in immune cells: Emerging role in cardiovascular disease
Bene, N. C., Alcaide, P., Wortis, H. H., & Jaffe, I. Z. (2014) · Steroids · doi:10.1016/j.steroids.2014.04.005 · Cited by 112
High Uric Acid Induces Insulin Resistance in Cardiomyocytes In Vitro and In Vivo
Li, Z., Zhu, Y., Huang, T., Hisatome, I., Yamamoto, T., & Jidong, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147737 · Cited by 112
van der Schaft, N., Brahimaj, A., Wen, K., Franco, O. H., & Dehghan, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179482 · Cited by 112
Prasad, M., Matteson, E. L., Herrmann, J., Gulati, R., Rihal, C. S., Lerman, L. O., & Lerman, A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.08436 · Cited by 110
Wang, R., Song, Y., Yan, Y., & Ding, Z. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.006 · Cited by 108
Papežíková, I., Pekarová, M., Kolářová, H., Klinke, A., Lau, D., Baldus, S. E., Lojek, A., & Kubala, L. (2012) · Free Radical Research · doi:10.3109/10715762.2012.747677 · Cited by 102
Gersch, C. M., Palii, S. P., Imaram, W., Kim, K. M., Karumanchi, S. A., Angerhofer, A., Johnson, R. J., & Henderson, G. N. (2009) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770902736400 · Cited by 102
von Lueder, T. G., Girerd, N., Atar, D., Agewall, S., Lamiral, Z., Kanbay, M., Pitt, B., Dickstein, K., Zannad, F. M., Rossignol, P., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.419 · Cited by 101
Sun, H., Pei, D., Lue, K., & Chen, Y.-L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143786 · Cited by 98
Huang, T., Hao, D., Wu, B., Mao, L., & Zhang, J. C. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.004 · Cited by 97
Yin, W., Zhou, Q., OuYang, S.-X., Chen, Y., Gong, Y., & Liang, Y. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1506-8 · Cited by 88
Liu, P., Wang, H., Zhang, F., et al. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.4310 · Cited by 87
Relationships Among Hyperuricemia, Metabolic Syndrome, and Endothelial Function
Tomiyama, H., Higashi, Y., Takase, B., Node, K., Sata, M., Inoue, T., Ishibashi, Y., Ueda, S., Shimada, K., & Yamashina, A. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.55 · Cited by 85
Kuwabara, M., Kuwabara, R., Hisatome, I., Niwa, K., Roncal-Jimenez, C. A., Bjornstad, P., Andrés-Hernando, A., Sato, Y., Jensen, T., García, G., et al. (2017) · Obesity · doi:10.1002/oby.22000 · Cited by 84
Vaduganathan, M., Greene, S. J., Ambrosy, A. P., Mentz, R. J., Subacius, H. P., Chioncel, O., Maggioni, A. P., Swedberg, K. B., Zannad, F. M., Konstam, M. A., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.09.008 · Cited by 79
Association between endothelial dysfunction and hyperuricaemia
Ho, W.-J., Tsai, W., Yu, K., Tsay, P., Wang, C.-L., Hsu, T. S., & Kuo, C.-T. (2010) · Rheumatology · doi:10.1093/rheumatology/keq184 · Cited by 77
Palazzuoli, A., Ruocco, G. M., Vivo, O. D., Nuti, R., & McCullough, P. A. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.06.057 · Cited by 74
Tomiyama, H., Shiina, K., Vlachopoulos, C. V., Iwasaki, Y., Matsumoto, C., Kimura, K., Fujii, M., Chikamori, T., & Yamashina, A. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11390 · Cited by 73
The Role of Uric Acid in Preeclampsia: Is Uric Acid a Causative Factor or a Sign of Preeclampsia?
Khaliq, O. P., Konoshita, T., Moodley, J., & Naicker, T. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0878-7 · Cited by 69
Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes
Singh, J. A., Ramachandaran, R., Yu, S., & Curtis, J. R. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0513-6 · Cited by 68
Milojković, B., Kocic, G. M., Radenkovic, S., Pavlović, R., Cvetković, T., Deljanin-Ilić, M., Ilić, S., Bobana, M. D., Djindjić, B., Stojanović, D. R., et al. (2014) · Renal Failure · doi:10.3109/0886022x.2014.882240 · Cited by 64
Effect of Uric Acid–Lowering Agents on Endothelial Function
Borgi, L., McMullan, C. J., Wohlhueter, A. L., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.08488 · Cited by 64
Maharani, N., Ting, Y., Cheng, J., Hasegawa, A., Kurata, Y., Li, P., Nakayama, Y., Ninomiya, H., Ikeda, N., Morikawa, K., et al. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0416 · Cited by 63
Self-citationKim, S., Choe, J., & Park, K.-Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.07.087 · Cited by 63
Xin, Y., Guo, Y., Li, Y., Ma, Y., Li, L., & Jiang, H. (2018) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2018.11.013 · Cited by 58
Chen, C., Chen, C., Chang, C., Lin, Y. J., Wang, C., Chi, C., Lu, C., Chen, W., Pan, R., Su, S., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1377 · Cited by 52
Serum Uric Acid and Risk of Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation
Tang, R., Dong, J., Yan, X., Du, X., Kang, J.-P., Wu, J., Yu, R., Long, D., Ning, M., Sang, C., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.06.009 · Cited by 50
Evidence for a Causal Role of Oxidative Stress in the Myocardial Complications of Insulin Resistance
Ritchie, R. H. (2009) · Heart Lung and Circulation · doi:10.1016/j.hlc.2008.11.003 · Cited by 49
Kramer, F., Voss, S., Roessig, L., Igl, B., Butler, J., Lam, C. S. P., Maggioni, A. P., Shah, S. J., & Pieske, B. M. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1787 · Cited by 49
Maruhashi, T., Nakashima, A., Soga, J., Fujimura, N., Idei, N., Mikami, S., Iwamoto, Y., Kajikawa, M., Matsumoto, T., Hidaka, T., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003659 · Cited by 46
Li, H., Qian, F., Liu, H., & Zhang, Z. (2019) · Medical Science Monitor · doi:10.12659/msm.916667 · Cited by 44
Alberts, B. M., Barber, J. S., Sacre, S. M., Davies, K. A., Ghezzi, P., & Mullen, L. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.180855 · Cited by 43
Chen, Y., Xia, Y., Han, X., Yang, Y., Yin, X., Qiu, J., Liu, H., Zhou, Y., & Liu, Y. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-019037 · Cited by 41
Association Between Serum Uric Acid Levels and Atrial Fibrillation Risk
Zhang, C., Huang, D., Shen, D., Zhang, L., Yongjiang, M., Wang, Y., & Sun, H. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000443099 · Cited by 40
Canpolat, U., Aytemir, K., Yorgun, H., ahiner, L., Kaya, E. B., Çay, S., lu, S. T., Aras, D., & Oto, A. (2014) · EP Europace · doi:10.1093/europace/euu198 · Cited by 39
Pegloticase Treatment Significantly Decreases Blood Pressure in Patients With Chronic Gout
Johnson, R. J., Choi, H. K., Yeo, A. E. T., & Lipsky, P. E. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12727 · Cited by 39
Mantovani, A., Rigolon, R., Civettini, A., Bolzan, B., Morani, G., Bonapace, S., Dugo, C., Zoppini, G., Bonora, E., & Targher, G. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0729-4 · Cited by 34
Lü, J., Sun, M., Wu, X., Yuan, X., Liu, Z., Qu, X.-J., Ji, X., Merriman, T. R., & Li, C. (2019) · FEBS Journal · doi:10.1111/febs.14768 · Cited by 34
Taufiq, F., Maharani, N., Li, P., Kurata, Y., Ikeda, N., Kuwabara, M., Otani, N., Miake, J., Hasegawa, A., Tsuneto, M., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-18-1088 · Cited by 34
Klisic, A. N., Kocic, G. M., Kavarić, N., Jovanović, M., Stanišić, V., & Ninić, A. (2017) · Clinical and Experimental Medicine · doi:10.1007/s10238-017-0483-0 · Cited by 32
Lin, W., Deng, H., Guo, P., Liu, F., Chen, R.-Y., Fang, X., Zhan, X., Liao, H., Huang, W., Liu, Y., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028007 · Cited by 22
Liang, W., Liu, W. W., Liu, M. L., Xiang, W., Feng, X. R., Huang, B., Chen, X. H., & Sun, Y. S. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.03.011 · Cited by 20
Pavlušová, M., Jarkovský, J., Benešová, K., Vítovec, J., Linhart, A., Widimský, P., Špinarová, L., Zeman, K., Bělohlávek, J., Málek, F., et al. (2019) · Clinical Cardiology · doi:10.1002/clc.23197 · Cited by 15
Kobayashi, N., Asai, K., Tsurumi, M., Shibata, Y., Okazaki, H., Shirakabe, A., Goda, H., Uchiyama, S., Tani, K., Takano, M., et al. (2018) · Cardiology · doi:10.1159/000496053 · Cited by 14
Dissociation between Urate and Blood Pressure in Mice and in People with Early Parkinson's Disease
Chen, X., Umeh, C. C., Tainsh, R. E. T., Feng, D. D., Maguire, M., Zuo, F., Rahimian, M., Logan, R. A., Wang, X., Ascherio, A., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.039 · Cited by 10
Singh, J. A., & Cleveland, J. D. (2017) · Rheumatology · doi:10.1093/rheumatology/kex232 · Cited by 8
Subsequent risk of gout for women with hypertensive disorders in pregnancy
Wang, I., Chen, J., Muo, C., Chou, C., Liu, Y., Lin, S.-Y., Liang, C., Yen, T., & Sung, F. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000888 · Cited by 3
Black‐Maier, E., & Daubert, J. P. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.07.006 · Cited by 3
Nidorf, M., & Jelinek, M. V. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317749039 · Cited by 2
Cited by
Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179221 · Cited by 595
Wearable plasmonic paper–based microfluidics for continuous sweat analysis
Mogera, U., Guo, H., Namkoong, M., Rahman, M. S., Nguyen, T., & Tian, L. (2022) · Science Advances · doi:10.1126/sciadv.abn1736 · Cited by 280
Metadata
- Authors
- Yu, W., & Cheng, J.-D.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2020-11-16
- Volume
- 11
- Pages
- 582680-582680
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3098915518
- Cited by
- 344
- References
- 107
- FWCI
- 21.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.